Targeting the urokinase plasminogen activator receptor with a monoclonal antibody impairs the growth of human colorectal cancer in the liver.

Targeting the urokinase plasminogen activator receptor with a monoclonal antibody impairs the growth of human colorectal cancer in the liver.

Item
http://www.wikidata.org/entity/Q36168520
Prostate cancer relevant antigens and enzymes for targeted drug deliveryIdentification of a New Epitope in uPAR as a Target for the Cancer Therapeutic Monoclonal Antibody ATN-658, a Structural Homolog of the uPAR Binding Integrin CD11b (αM)Co-depletion of cathepsin B and uPAR induces G0/G1 arrest in glioma via FOXO3a mediated p27 upregulation.Targeting the urokinase plasminogen activator receptor inhibits ovarian cancer metastasis.Expression of uPAR in tumor-associated stromal cells is associated with colorectal cancer patient prognosis: a TMA studyMechanism of p27 upregulation induced by downregulation of cathepsin B and uPAR in gliomaIdentification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors.Regulation of u-PAR gene expression by H2A.Z is modulated by the MEK-ERK/AP-1 pathway.uPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgeryA novel animal model for in vivo study of liver cancer metastasis.The many spaces of uPAR: delivery of theranostic agents and nanobins to multiple tumor compartments through a single targetModulators of the urokinase-type plasminogen activation system for cancer.Development of novel therapeutics targeting the urokinase plasminogen activator receptor (uPAR) and their translation toward the clinic.An anti-urokinase plasminogen activator receptor antibody (ATN-658) blocks prostate cancer invasion, migration, growth, and experimental skeletal metastasis in vitro and in vivo.Evaluating the value of uPAR of serum and tissue on patients with cervical cancer.Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications.
P2860

Targeting the urokinase plasminogen activator receptor with a monoclonal antibody impairs the growth of human colorectal cancer in the liver.

Item
http://www.wikidata.org/entity/Q36168520
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Targeting the urokinase plasmi ...... olorectal cancer in the liver.
@ast
Targeting the urokinase plasmi ...... olorectal cancer in the liver.
@en
type
label
Targeting the urokinase plasmi ...... olorectal cancer in the liver.
@ast
Targeting the urokinase plasmi ...... olorectal cancer in the liver.
@en
prefLabel
Targeting the urokinase plasmi ...... olorectal cancer in the liver.
@ast
Targeting the urokinase plasmi ...... olorectal cancer in the liver.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Targeting the urokinase plasmi ...... olorectal cancer in the liver.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932